Showing results (11-20 of 947) with videos related to
Sort By:
Pageof 95
Journal of Clinical Psychopharmacology|August 1, 1988
Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranesP SeemanJournal of Pharmacological Methods|July 1, 1987
The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptorsP SeemanMolecular Psychiatry|September 17, 2002
NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophreniaS Kapur, P SeemanThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1977
Conduction-blocking concentrations of anesthetics increase with nerve axon diameter: studies with alcohol, lidocaine and tetrodotoxin on single myelinated fibersA Staiman, P SeemanClinical Genetics|May 3, 2006
High prevalence of the IVS 1 + 1 G to A/GJB2 mutation among Czech hearing impaired patients with monoallelic mutation in the coding region of GJB2P Seeman, I SakmaryováCanadian Journal of Physiology and Pharmacology|March 1, 1982
Effects of antihypertensive clonidine congeners on alpha-adrenergic receptorsM Titeler, P SeemanEuropean Journal of Pharmacology|October 17, 1980
Presynaptically acting catecholamines bind to alpha 2-adrenoceptors labelled by 3H-clonidineM Titeler, P SeemanExperientia|November 15, 1978
Antiparkinsonian drug doses and neuroleptic receptorsM Titeler, P SeemanMolecular Psychiatry|May 13, 1998
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptorsP Seeman, T TallericoThe American Journal of Psychiatry|June 9, 1999
Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapineP Seeman, T TallericoPageof 95